Physician profile
Brendan Browne
NPI 1063772770
$52,516.96
in general payments reported to CMS, 2019-2025
7 companies · $22K in 2025
The $22K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $90.61 · 2021: $103 · 2022: $26K · 2023: $3,608 · 2024: $849 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Travel and Lodging: $2,534 · Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,525.00 |
| Travel and Lodging | $2,533.80 |
| Food and Beverage | $1,569.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $49,466.33 | 2022-2025 | Litho 150, Fiber Dust |
| Cook Medical LLC | $2,593.07 | 2020-2025 | Litho 150, Resonance, Fiber Dust |
| Boston Scientific Corporation | $302.63 | 2025 | General - Bph, Lithovue, General - Kidney Stone Disease |
| Procept Biorobotics Corporation | $95.48 | 2022 | |
| Histosonics, INC. | $33.25 | 2025 | |
| Endo Pharmaceuticals INC. | $22.38 | 2022 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Browne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.